Atria maintained its outlook intact and expects adjusted EBIT to decline in 2022 (after EUR 49.2m in 2021) while we have modelled EUR 33m. We view strong Q2 results positively while we note higher expectations for H2 as we have expected price increases to take full effect in H2, while it appears that the company has been very successful with its pricing actions already in Q2.
Aktuellt
SENASTE
